Introduction
============

Schizophrenia is a chronic, severe mental disorder with a tremendously variable clinical presentation. Results of studies in which schizophrenia occurrence was evaluated among twins or children who were adopted have shown that this disease results from an interaction of genetics and environmental factors.[@b1-ndt-14-153] Specifically, schizophrenia is a multigene disease with a heritability of 60%--70%.[@b2-ndt-14-153] Although the pathogenesis and etiology of schizophrenia are not understood fully,[@b3-ndt-14-153] a large body of evidence has indicated that dopamine dysfunction is involved in the occurrence of this disease.[@b4-ndt-14-153]--[@b6-ndt-14-153]

Dopamine is an endogenous neurotransmitter that primarily functions by binding to dopamine receptors, which have five types. The D4 receptor has attracted attention in the field of schizophrenia research. In postmortem brain striatum of patients with schizophrenia, the density of D4 receptor was significantly higher than in brain tissues of unaffected patients; in contrast, the density of D2 and D3 receptors remained modest.[@b7-ndt-14-153] This upregulation of D4 receptor has been shown to be related to the disease rather than to pharmacological effects of treatment.[@b8-ndt-14-153] The pharmacological characteristics of D4 resemble those of D2 and D3, but the affinity of D4 for clozapine is an order of magnitude higher.[@b9-ndt-14-153] Hence, *DRD4* (chromosome 11p15.5) is a potential susceptibility gene for schizophrenia.[@b10-ndt-14-153]

The SZGene database is a viable resource for ascertaining the risk of schizophrenia.[@b11-ndt-14-153],[@b12-ndt-14-153] Other investigators have determined that the −521 C\>T and 120 bp tandem repeat (TR) polymorphisms in *DRD4* are associated with nominally significant summary odds ratios (ORs) as risk factors for schizophrenia (*P*=0.003 and 0.005, respectively).[@b11-ndt-14-153] However, despite a great deal of research, an association between *DRD4* polymorphisms and schizophrenia risk remains debatable.

TRs in *DRD4* include a 48 bp variable number TR (VNTR), a 12 bp TR, and a 120 bp TR. The 48 bp VNTR is located in the third exon of *DRD4* and encodes a sequence of 16 amino acids in the region of the third cytoplasmic loop. Polymorphisms in the 48 bp VNTR were found to differ in the recruitment of cellular cAMP.[@b13-ndt-14-153] The 12 bp TR (rs4646983) is located in the first exon of *DRD4*, which corresponds to the N terminus of the gene product. Variants of the 12 bp TR modify an N-terminal glycosylation site, which affects expression levels of the membrane protein.[@b14-ndt-14-153] The 120 bp TR is located 1.2 kb upstream from the initiation codon, and polymorphisms at this site affect transcriptional efficiency.[@b15-ndt-14-153] Some researchers noted that the 120 bp TR was associated with attention-deficit hyperactivity disorder (ADHD)[@b16-ndt-14-153],[@b17-ndt-14-153] and schizophrenia.[@b18-ndt-14-153] However, Tsutsumi et al[@b19-ndt-14-153] demonstrated that the 120 bp TR was not related to the risk of schizophrenia.

The −521 C\>T polymorphism (rs1800955), located in the promoter region of *DRD4*, has been shown to be associated with novelty seeking[@b20-ndt-14-153],[@b21-ndt-14-153] and schizophrenia.[@b22-ndt-14-153] Mitsuyasu et al suggested that the −521C variant could be a risk factor for schizophrenia among female patients.[@b23-ndt-14-153] However, other investigators found no relationship between −521 C\>T and schizophrenia.[@b24-ndt-14-153] The −616 C\>G (rs747302) and the −376 C\>T (rs916455) polymorphisms are located in the promoter region of *DRD4*; these variants have not been associated conclusively with schizophrenia risk. A pooled analysis of data regarding polymorphisms in *DRD4* and schizophrenia risk is warranted.

Meta-analyses are proven tools for ascertaining associations of gene polymorphisms with disease.[@b25-ndt-14-153]--[@b27-ndt-14-153] Several meta-analyses previously have addressed the potential associations between *DRD4* polymorphisms and schizophrenia risk.[@b28-ndt-14-153]--[@b31-ndt-14-153] However, the authors of these studies examined just one polymorphic locus[@b28-ndt-14-153] or did not include the latest data.[@b31-ndt-14-153] Herein, we describe the results of our meta-analysis of the association between *DRD4* and schizophrenia risk.

Materials and methods
=====================

Literature searches
-------------------

The SZGene, PubMed, and China National Knowledge Infrastructure (CNKI) databases were searched with the keywords "schizophrenia" and "*DRD4*". Reference lists from relevant articles also were screened to identify additional studies.

Inclusion criteria and exclusion criteria
-----------------------------------------

Studies with the following features were included in the meta-analysis: 1) case--control design; 2) involved patients with schizophrenia; 3) presented relevant data for case and control groups (eg, allele/genotype frequencies, sample size, ethnicity, schizophrenia diagnostic criteria, and control group source); 4) removed duplicate sample data; and 5) published before September 1, 2017. Studies were excluded for the following reasons: 1) no control group; 2) no usable genotype frequency data (attempts were made to contact authors via email for these data); and 3) duplicate reported sample data.

Statistical analysis
--------------------

A meta-analysis was carried out using Stata Version 10.0 (StataCorp LP, College Station, TX, USA). The *P*-value of Hardy--Weinberg equilibrium (*P*~HWE~) was calculated for the control groups. ORs and 95% confidence intervals (CIs) were calculated to evaluate the strength of the associations. Under a random model,[@b32-ndt-14-153],[@b33-ndt-14-153] associations between *DRD4* and the risk of schizophrenia were analyzed. A random model took into account population differences and heterogeneity among studies.[@b25-ndt-14-153],[@b34-ndt-14-153] Pairwise differences between genotypes (AA vs aa, Aa vs aa, and AA vs Aa \[A being the risk factor\]) were used to determine a suitable genetic model.[@b35-ndt-14-153]

The heterogeneity of the studies was determined by Cochran's chi-square-based *Q*-statistic test.[@b36-ndt-14-153] The degree of heterogeneity was expressed as *I*[@b2-ndt-14-153] and was divided into low (*I*[@b2-ndt-14-153]\<25%), medium (*I*[@b2-ndt-14-153]\~50%), and high (*I*[@b2-ndt-14-153]\>75%) heterogeneity groups.[@b37-ndt-14-153] *I*[@b2-ndt-14-153]\>50% was regarded as indicating substantial heterogeneity.[@b38-ndt-14-153] Publication bias was calculated using Egger's test and was represented as a funnel plot in which the standard error of log(OR) of each study was plotted against its log(OR). A sensitivity analysis was conducted to test the impact of removing each single study on the pooled result. Statistical power was calculated by means of the PS program, as described previously.[@b39-ndt-14-153],[@b40-ndt-14-153] *P*-values corresponding to association, heterogeneity, and publication bias tests were represented as *P*~z~, *P*~h~, and *P*~e~, respectively. Statistical significance was defined as *P*\<0.05 for all analyses.[@b41-ndt-14-153]

Results
=======

Description of studies
----------------------

A total of 211 English-language articles were obtained from SZGene and PubMed, and 14 Chinese-language articles were obtained from CNKI. After removing duplicate studies and those that did not meet our inclusion criteria, 41 articles were used in the meta-analysis ([Figure 1](#f1-ndt-14-153){ref-type="fig"}). Specifically, 28 articles addressed the 48 bp VNTR,[@b23-ndt-14-153],[@b42-ndt-14-153]--[@b68-ndt-14-153] nine articles involved the 12 bp TR,[@b23-ndt-14-153],[@b43-ndt-14-153],[@b48-ndt-14-153]--[@b50-ndt-14-153],[@b69-ndt-14-153]--[@b72-ndt-14-153] six articles pertained to the 120 bp TR,[@b18-ndt-14-153],[@b19-ndt-14-153],[@b65-ndt-14-153],[@b72-ndt-14-153]--[@b74-ndt-14-153] 10 articles addressed the −521 C\>T polymorphism,[@b18-ndt-14-153],[@b22-ndt-14-153]--[@b24-ndt-14-153],[@b58-ndt-14-153],[@b72-ndt-14-153]--[@b76-ndt-14-153] six articles referred to −616 C\>G,[@b18-ndt-14-153],[@b23-ndt-14-153],[@b72-ndt-14-153],[@b74-ndt-14-153]--[@b76-ndt-14-153] and four articles entailed −376 C\>T.[@b18-ndt-14-153],[@b23-ndt-14-153],[@b72-ndt-14-153],[@b75-ndt-14-153] Details of these studies are listed in [Table 1](#t1-ndt-14-153){ref-type="table"}. We omitted loci from our meta-analysis that were not represented in at least four articles.

Results of data analysis
------------------------

### No association between the 48 bp VNTR and schizophrenia risk

Allele frequencies of the 48 bp VNTR are listed in [Table 2](#t2-ndt-14-153){ref-type="table"}. Results of pooled analyses are summarized in [Table 3](#t3-ndt-14-153){ref-type="table"}, and data from subgroup analyses are depicted in [Table 4](#t4-ndt-14-153){ref-type="table"}. We were unable to obtain specific data regarding the number of 7-repeat (7R) alleles in the 48 bp VNTR,[@b44-ndt-14-153] despite multiple attempts to contact the corresponding author. Thus, this study was omitted from our analysis of an association between 7R and schizophrenia risk. When we conducted a pooled analysis of the remaining 5,316 cases and 4,677 controls, we found that 7R was not associated with schizophrenia risk (*P*~z~=0.349, OR =1.071, 95% CI =0.928--1.236) under a random effects model with a power of 0.271 ([Table 3](#t3-ndt-14-153){ref-type="table"} and Figure S1).[@b35-ndt-14-153] No association was found in subgroup analysis by ethnicity (ie, Caucasian \[*P*~z~=0.238, OR =1.127, 95% CI =0.924--1.375\], East Asian \[*P*~z~=0.901, OR =0.966, 95% CI =0.560--1.667\], Indian \[*P*~z~=0.211, OR =0.772, 95% CI =0.514--1.158\], Mestizos \[*P*~z~=0.310, OR =1.413, 95% CI =0.725--2.754\], and Israeli \[*P*~z~=0.512, OR =1.164, 95% CI =0.739--1.835\]). Moreover, no association of 7R with the risk of schizophrenia was ascertained in subgroup analysis by source of controls. No significant heterogeneity was found in the pooled or subgroup analyses.

To incorporate data from the study of Serretti et al,[@b44-ndt-14-153] the 48 bp VNTR was classified into S (short allele, ≤4 TRs) and L (long allele, ≥5 TRs) groups. In the study by Kohn et al,[@b43-ndt-14-153] the 48 bp VNTR data could not be categorized into S and L groups, so this study was omitted from the analysis. The remaining data comprised 5,637 cases and 5,074 controls ([Table 3](#t3-ndt-14-153){ref-type="table"} and Figure S2). Results of a pooled analysis indicated no relationship between this polymorphism and schizophrenia risk (*P*~z~=0.073, OR =1.135, 95% CI =0.988--1.303) with a power of 0.909. No association was found in the subgroup analysis by source of control or by ethnicity, except for Mestizos (*P*~z~=0.048, OR =1.949, 95% CI =1.007--3.77). Significant heterogeneity was found in the pooled analysis (*P*~e~=0.009, *I*[@b2-ndt-14-153]=44%) and in the subgroup analysis by ethnicity in the East Asian subgroup (*P*~e~=0.014, *I*[@b2-ndt-14-153]=49.1%) and by source of control in the hospital-based subgroup (*P*~e~=0.016, *I*[@b2-ndt-14-153] =59.2%).

### No association between the 12 bp TR and schizophrenia risk

To evaluate the relationship between the 12 bp TR and the risk of schizophrenia, 1,517 cases and 1,746 controls were included ([Table 5](#t5-ndt-14-153){ref-type="table"} and Figures S3--S7). Allele groups were defined as in (ie, inserted) and de (ie, deleted). In the dominant model,[@b34-ndt-14-153],[@b35-ndt-14-153] the pooled OR using a random effects model was 1.083 (*P*~z~=0.377, 95% CI =0.907--1.293) with a power of 0.154 ([Table 3](#t3-ndt-14-153){ref-type="table"}). No association was found in subgroup analysis by ethnicity or by source of controls ([Table 4](#t4-ndt-14-153){ref-type="table"}). No significant heterogeneity was observed in the pooled or subgroup analyses.

### Genotype L/L of the 120 bp TR might be a risk factor for schizophrenia

In a random model, a pooled analysis was conducted (1,912 cases and 1,836 controls) to evaluate the relationship between genotype L/L of the 120 bp TR and schizophrenia risk ([Table 6](#t6-ndt-14-153){ref-type="table"} and Figures S8--S12). In the recessive model,[@b34-ndt-14-153],[@b35-ndt-14-153] genotype L/L was found to be a potential risk factor for schizophrenia (*P*~z~=0.004, OR =1.275, 95% CI =1.081--1.504) with a power of 0.959 ([Table 3](#t3-ndt-14-153){ref-type="table"}). Findings from subgroup analysis indicated significant associations in East Asian (*P*~z~=0.002, OR =1.317, 95% CI =1.108--1.565) and hospital-based subgroups (*P*~z~=0.002, OR =1.319, 95% CI =1.134--1.708) ([Table 4](#t4-ndt-14-153){ref-type="table"}). No association was found for the other subgroups, and no significant heterogeneity was ascertained in the pooled or subgroup analyses.

### The −521 CC variant might be a risk factor for schizophrenia

Pooled and subgroup analyses were performed in a random model with 2,927 cases and 2,938 controls ([Table 7](#t7-ndt-14-153){ref-type="table"} and Figures S13--S17). In the recessive model, −521 CC was found to be a potential risk factor for schizophrenia in the pooled analysis (*P*~z~=0.021, OR =1.177, 95% CI =1.024--1.353) with a power of 0.656 ([Table 3](#t3-ndt-14-153){ref-type="table"}). In subgroup analyses by ethnicity and source of controls, the association was only detected in the East Asian subgroup (*P*~z~=0.009, OR =1.218, 95% CI =1.050--1.413) ([Table 4](#t4-ndt-14-153){ref-type="table"}). No significant heterogeneity was noted in the pooled or subgroup analyses.

### No association between −616 C\>G and the risk of schizophrenia

In a random model, pooled ([Table 3](#t3-ndt-14-153){ref-type="table"}) and subgroup ([Table 4](#t4-ndt-14-153){ref-type="table"}) analyses were performed with 1,735 cases and 1,724 controls ([Table 8](#t8-ndt-14-153){ref-type="table"} and Figures S18--S22). Using the dominant model, results of the pooled analysis indicated a lack of an association between −616 C\>G and schizophrenia risk (*P*~z~=0.068, OR =1.133, 95% CI =0.991--1.295) with a power of 0.45. All cases and controls in this analysis corresponded to the East Asian subgroup. Findings from a subgroup analysis of source of controls showed no association. There was no significant heterogeneity in the pooled or subgroup analyses.

### No association of the −376 C\>T variant with schizophrenia

We assessed the relationship between the −376 C\>T polymorphism and schizophrenia risk in pooled and subgroup analyses of 1,191 cases and 1,215 controls in a random model ([Tables 3](#t3-ndt-14-153){ref-type="table"}, [4](#t4-ndt-14-153){ref-type="table"}, and [9](#t9-ndt-14-153){ref-type="table"} and Figures S23--S27). In the recessive model, −376 C\>T was not associated with the risk of schizophrenia in a pooled analysis (*P*~z~=0.117, OR =1.171, 95% CI =0.962--1.425) with a power of 0.357 ([Table 3](#t3-ndt-14-153){ref-type="table"}). No association was detected in subgroup analyses by ethnicity or source of controls ([Table 4](#t4-ndt-14-153){ref-type="table"}). No significant heterogeneity was ascertained in the pooled or subgroup analyses.

### Sensitivity analysis

The results of sensitivity analyses showed that the combined ORs did not change significantly for meta-analyses in which each study was omitted singly. Thus, the results were considered stable and reasonable.

### Publication bias

Potential publication bias was found in funnel plots in which the standard error of log(OR) of each study was plotted against its log(OR). No evidence of publication bias was found in pooled analyses ([Figures 2](#f2-ndt-14-153){ref-type="fig"}[](#f3-ndt-14-153){ref-type="fig"}[](#f4-ndt-14-153){ref-type="fig"}[](#f5-ndt-14-153){ref-type="fig"}[](#f6-ndt-14-153){ref-type="fig"}[](#f7-ndt-14-153){ref-type="fig"}--[8](#f8-ndt-14-153){ref-type="fig"}).

Discussion
==========

Results of other studies have associated the 7R polymorphism with ADHD in a meta-analysis[@b77-ndt-14-153] and with increased brain activity to unpleasant stimuli.[@b78-ndt-14-153] We sought to determine whether 7R was also associated with schizophrenia risk. Findings of our pooled and subgroup analyses indicated that 7R was not associated with the risk of schizophrenia. Similarly, we found that the 48 bp VNTR (classified into L and S groups) was not associated with schizophrenia risk in most of our pooled and subgroup analyses, which is consistent with previously published meta-analyses.[@b29-ndt-14-153],[@b30-ndt-14-153] Only in the Mestizos subgroup, an association was detected. Our literature search yielded one article addressing Mestizos patients, and this article had an insufficient sample size to verify this association. Hence, the utility of the 48 bp VNTR as a means to assess schizophrenia risk in the Mestizo population warrants additional investigation. Lung et al[@b28-ndt-14-153] demonstrated an association between the 48-bp VNTR and schizophrenia risk but noted that sample bias might have led to a false-positive result.[@b29-ndt-14-153]

We determined that the L/L genotype of the 120 bp TR and the −521 CC variant might be risk factors for schizophrenia among East Asians; this relationship was not found in other populations. This discrepancy between East Asians and other populations might have resulted from the small sample sizes of the other ethnicity subgroups, the distinct genetic backgrounds, or different demographic or lifestyle factors within the subgroups. The statistical power for the pooled analysis of the 12 bp TR, the −616 C\>G polymorphism, and the −376 C\>T variant was low. Therefore, these results will need to be validated further. In a study of linkage disequilibrium (LD) of *DRD4* that included 17 polymorphisms,[@b23-ndt-14-153] the authors found no LD between −521 T\>C and 120 bp TR (*r*[@b2-ndt-14-153]=0.00). For all pairs of −616 C\>G, −376 C\>T, 12 bp TR, and 48 bp VNTR, no significant LD was observed.

Multiple meta-analyses have been conducted to date on the association between *DRD4* and schizophrenia. The current meta-analysis included some new studies, involved a large sample size, and had high statistical power. We addressed six loci in *DRD4*; no other meta-analysis involving four of these loci (12 bp TR, 120 bp TR, −616 C\>G, and −376 C\>T) has been carried out. Moreover, we conducted subgroup analysis by ethnicity and by source of controls and included data both from SZGene and the CNKI databases.

The results described herein should be interpreted with caution. The present study was limited by a lack of exact allele/genotype frequencies for some of the included articles, despite our efforts to acquire this information from the corresponding authors. Therefore, these articles were omitted from the meta-analysis. Second, controls in some of the articles did not conform to Hardy--Weinberg equilibrium because of sample bias. Third, case--control studies were included in this meta-analysis, but family-based studies were not.[@b77-ndt-14-153] The ability to exploit cosegregation of variants with disease within families helps distinguish causal from noncausal factors. Family-based studies are more powerful to detect risk factors of diseases.[@b79-ndt-14-153] Moreover, we did not address possible interactions between the six loci and epigenetic factors. An association between *DRD4* and schizophrenia risk was detected based on case--control studies rather than on functional ones. Our results will need to be validated on a functional level.

Conclusion
==========

The −521 CC variant and the L/L genotype of the 120-bp TR might be risk factors for schizophrenia. No association with schizophrenia was detected for the 48 bp VNTR, the 12 bp TR, −616 C\>G, or −376 C\>T. Our results may provide an informative reference for subsequent genome-wide association studies.
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![Study selection process in this meta-analysis.\
**Abbreviations:** CNKI, China National Knowledge Infrastructure; VNTR, variable number tandem repeat.](ndt-14-153Fig1){#f1-ndt-14-153}

![Funnel plot analysis for the detection of publication bias in the association between the 48 bp VNTR (7R vs others) and schizophrenia.\
**Abbreviations:** OR, odds ratio; 7R, 7 repeat; VNTR, variable number tandem repeat.](ndt-14-153Fig2){#f2-ndt-14-153}

![Funnel plot analysis for the detection of publication bias in the association between 48 bp VNTR (L vs S) and schizophrenia.\
**Notes:** L, long allele; S, short allele.\
**Abbreviations:** OR, odds ratio; VNTR, variable number tandem repeat.](ndt-14-153Fig3){#f3-ndt-14-153}

![Funnel plot analysis for the detection of publication bias in the association between 12 bp TR and schizophrenia.\
**Abbreviations:** OR, odds ratio; TR, tandem repeat.](ndt-14-153Fig4){#f4-ndt-14-153}

![Funnel plot analysis for the detection of publication bias in the association between 120 bp TR and schizophrenia.\
**Abbreviations:** OR, odds ratio; TR, tandem repeat.](ndt-14-153Fig5){#f5-ndt-14-153}

![Funnel plot analysis for the detection of publication bias in the association between −521 C\>T and schizophrenia.\
**Abbreviation:** OR, odds ratio.](ndt-14-153Fig6){#f6-ndt-14-153}

![Funnel plot analysis for the detection of publication bias in the association between −616 C\>G and schizophrenia.\
**Abbreviation:** OR, odds ratio.](ndt-14-153Fig7){#f7-ndt-14-153}

![Funnel plot analysis for the detection of publication bias in the association between −376 C\>T and schizophrenia.\
**Abbreviation:** OR, odds ratio.](ndt-14-153Fig8){#f8-ndt-14-153}

###### 

Characteristics of studies that qualified to be included in the meta-analysis

  Author                                                                        Year         Country       Ethnicity    Controls source    Mean age of control group   Gender index (case)   Gender index (control)
  ----------------------------------------------------------------------------- ------------ ------------- ------------ ------------------ --------------------------- --------------------- ------------------------
  Kaiser et al[@b42-ndt-14-153]                                                 2000         German        Caucasian    Hospital based     43.53                       0.83                  0.34
  Kohn et al[@b43-ndt-14-153],[a](#tfn1-ndt-14-153){ref-type="table-fn"}        1997         Israel        Israeli      Hospital based     --                          --                    --
  Kohn et al[@b43-ndt-14-153],[b](#tfn2-ndt-14-153){ref-type="table-fn"}        1997         Israel        Israeli      Hospital based     --                          --                    --
  Serretti et al[@b44-ndt-14-153],[@b69-ndt-14-153]                             1999, 2001   Italy         Caucasian    Hospital based     47.45                       --                    1.27
  Hattori et al[@b45-ndt-14-153]                                                2009         Japan         East Asian   Population based   46.70                       1.00                  1.00
  Tanaka et al[@b46-ndt-14-153]                                                 1995         Japan         East Asian   Population based   45.80                       0.84                  0.56
  Nanko et al[@b47-ndt-14-153]                                                  1993         Japan         East Asian   Population based   --                          --                    --
  Petronis et al[@b48-ndt-14-153]                                               1995         USA, Canada   Caucasian    Hospital based     --                          --                    --
  Ohara et al[@b49-ndt-14-153]                                                  1996         Japan         East Asian   Population based   34.40                       0.99                  1.37
  Aguirre et al[@b50-ndt-14-153]                                                2007         Mexico        Indian       Population based   40.00                                             0.97
  Mitsuyasu et al[@b23-ndt-14-153],[c](#tfn3-ndt-14-153){ref-type="table-fn"}   2007         Japan         East Asian   Hospital based     50.20                       0.81                  0.76
  Daniels et al[@b51-ndt-14-153]                                                1994         UK            Caucasian    Hospital based     49.60                       0.80                  0.68
  Sommer et al[@b52-ndt-14-153]                                                 1993         Minnesota     Caucasian    Population based   65.00                       0.44                  1.61
  Rao et al[@b53-ndt-14-153]                                                    1994         USA           Caucasian    Population based   --                          --                    --
  Hong et al[@b54-ndt-14-153]                                                   1997         Taiwan        East Asian   Hospital based     28.70                       0.68                  0.62
  Jonsson et al[@b55-ndt-14-153]                                                1996         Sweden        Caucasian    Population based   38.70                       0.573                 0.73
  Rinetti et al[@b56-ndt-14-153]                                                2001         Mexico        Mestizos     Hospital based     --                          --                    --
  Fujiwara et al[@b57-ndt-14-153]                                               1997         Japan         East Asian   Population based   --                          --                    --
  Lung et al[@b58-ndt-14-153]                                                   2006         Taiwan        East Asian   Population based   45.37                       --                    --
  Nakamura et al[@b59-ndt-14-153]                                               1995         Japan         East Asian   Population based   --                          --                    --
  Lung et al[@b60-ndt-14-153]                                                   2009         Taiwan        East Asian   Population based   --                          --                    --
  Fresan et al[@b61-ndt-14-153]                                                 2007         Mexico        Caucasian    Population based   34.60                       0.45                  94.23
  Zhang et al[@b62-ndt-14-153]                                                  2003         China         East Asian   Population based   42.00                       0.43                  --
  Tang et al[@b68-ndt-14-153]                                                   2001         China         East Asian   Population based   33.00                       0.44                  0.40
  Liang[@b67-ndt-14-153]                                                        2005         China         East Asian   Population based   26.00                       0.98                  0.98
  Zhao et al[@b63-ndt-14-153]                                                   2005         China         East Asian   Population based   34.00                       0.88                  0.88
  Zhao et al[@b64-ndt-14-153]                                                   2006         China         East Asian   Population based   29.40                       0.84                  1.00
  Chen et al[@b65-ndt-14-153]                                                   2016         China         East Asian   Hospital based     39.19                       0.81                  0.89
  Lu et al[@b66-ndt-14-153]                                                     2003         China         East Asian   Population based   65.00                       0.74                  1.22
  Serretti et al[@b69-ndt-14-153]                                               1999         Italy         Caucasian    Population based   --                          --                    --
  Hong et al[@b70-ndt-14-153]                                                   1998         Taiwan        East Asian   Hospital based     30.20                       28.70                 0.62
  Catalano et al[@b71-ndt-14-153]                                               1993         Italy         Caucasian    Hospital based     46.90                       30.00                 1.34
  Nakajima et al[@b72-ndt-14-153]                                               2007         Japan         East Asian   Population based   47.00                       46.70                 1.00
  Okuyama et al[@b22-ndt-14-153]                                                1999         Japan         East Asian   Population based   47.10                       47.90                 0.63
  Mitsuyasu et al[@b75-ndt-14-153],[d](#tfn4-ndt-14-153){ref-type="table-fn"}   2001         Japan         East Asian   Hospital based     51.50                       50.50                 0.75
  Jonsson et al[@b24-ndt-14-153]                                                2001         Sweden        Caucasian    Population based   44.80                       42.60                 0.80
  Pai et al[@b73-ndt-14-153]                                                    2015         India         Indian       Population based   --                          --                    --
  Xing et al[@b18-ndt-14-153]                                                   2003         China         East Asian   Hospital based     41.20                       41.80                 --
  Lai et al[@b74-ndt-14-153]                                                    2010         China         East Asian   Hospital based     40.60                       43.20                 1.00
  Zhong et al[@b76-ndt-14-153]                                                  2010         China         East Asian   Population based   39.20                       37.50                 1.00
  Tsutsumi et al[@b19-ndt-14-153]                                               2011         Japan         East Asian   Hospital based     47.20                       42.10                 0.50

**Notes:** Gender index = female/male.

Ethnicity is Ashkenazi which included Jews whose origin (or whose parents' origin), was in European countries, apart from the Balkans;

ethnicity is non-Ashkenazi which included Jews whose origin was in North Africa or Asia.

Included 48 bp VNTR, 12 bp TR, and 120 bp TR;

did not include 48 bp VNTR, 12 bp TR, and 120 bp TR.

###### 

Allele frequency of 48 bp VNTR polymorphism

  Author                                                                        Allele distribution   Allele frequency                                     
  ----------------------------------------------------------------------------- --------------------- ------------------ ------- ----- ----- ------- ----- -------
  Kaiser et al[@b42-ndt-14-153]                                                 1,006                 270                1,182   322   232   1,044   282   1,222
  Kohn et al[@b43-ndt-14-153],[a](#tfn6-ndt-14-153){ref-type="table-fn"}        --                    --                 --      --    22    76      52    238
  Kohn et al[@b43-ndt-14-153],[b](#tfn7-ndt-14-153){ref-type="table-fn"}        --                    --                 --      --    13    85      17    101
  Serretti et al[@b44-ndt-14-153],[@b69-ndt-14-153]                             709                   129                990     212   --    --      --    --
  Hattori et al[@b45-ndt-14-153]                                                1,066                 54                 1,076   60    2     1,118   6     1,130
  Tanaka et al[@b46-ndt-14-153]                                                 134                   6                  133     7     0     140     2     138
  Nanko et al[@b47-ndt-14-153]                                                  148                   12                 152     10    2     158     0     162
  Petronis et al[@b48-ndt-14-153]                                               77                    23                 154     46    21    79      32    168
  Ohara et al[@b49-ndt-14-153]                                                  286                   20                 227     15    18    288     10    232
  Aguirre et al[@b50-ndt-14-153]                                                120                   72                 224     114   46    146     98    240
  Mitsuyasu et al[@b23-ndt-14-153],[c](#tfn8-ndt-14-153){ref-type="table-fn"}   406                   18                 447     27    1     423     3     471
  Daniels et al[@b51-ndt-14-153]                                                159                   53                 193     45    52    160     45    193
  Sommer et al[@b52-ndt-14-153]                                                 182                   48                 171     59    43    187     54    176
  Rao et al[@b53-ndt-14-153]                                                    39                    17                 31      9     17    39      8     32
  Hong et al[@b54-ndt-14-153]                                                   172                   6                  78      6     0     178     0     84
  Jonsson et al[@b55-ndt-14-153]                                                187                   49                 124     28    42    194     23    129
  Rinetti et al[@b56-ndt-14-153]                                                36                    38                 48      26    31    43      25    49
  Fujiwara et al[@b57-ndt-14-153]                                               34                    0                  22      0     0     34      0     22
  Lung et al[@b58-ndt-14-153]                                                   1,216                 44                 846     10    3     1,257   0     856
  Nakamura et al[@b59-ndt-14-153]                                               189                   13                 98      6     0     202     0     104
  Lung et al[@b60-ndt-14-153]                                                   1,774                 54                 838     8     0     1,828   0     846
  Fresan et al[@b61-ndt-14-153]                                                 88                    54                 285     119   47    95      104   300
  Zhang et al[@b62-ndt-14-153]                                                  131                   3                  145     7     0     134     0     152
  Tang et al[@b68-ndt-14-153]                                                   980                   40                 332     10    1     1,019   0     342
  Liang[@b67-ndt-14-153]                                                        176                   26                 185     25    4     198     2     208
  Zhao et al[@b63-ndt-14-153]                                                   78                    246                75      249   3     321     6     318
  Zhao et al[@b64-ndt-14-153]                                                   41                    121                40      136   0     162     3     173
  Chen et al[@b65-ndt-14-153]                                                   219                   49                 299     37    0     268     0     336
  Lu et al[@b66-ndt-14-153]                                                     155                   5                  157     3     1     159     0     160

**Notes:**

Ethnicity is Ashkenazi which included Jews whose origin (or whose parents' origin), was in European countries, apart from the Balkans;

ethnicity is non-Ashkenazi which included Jews whose origin was in North Africa or Asia.

Included 48 bp VNTR, 12 bp TR, and 120 bp TR.

**Abbreviations:** 7R, 7 repeat; VNTR, variable number tandem repeat.

###### 

Pooled associations of *DRD4* polymorphisms and schizophrenia

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Loci                        Genetic model                     Studies\   Statistical model   OR             95% CI         *P*~z~   *I*[@b2-ndt-14-153]   *P*~h~   *P*~e~
                                                                (n)                                                                                                  
  --------------------------- --------------------------------- ---------- ------------------- -------------- -------------- -------- --------------------- -------- --------
  48 bp VNTR                  Allele contrast (7R and others)   27         Random              1.071          0.928--1.236   0.349    8.1                   0.352    0.727

  Allele contrast (S and L)   27                                Random     1.135               0.988--1.303   0.073          44.0     0.009                 0.151    

  12 bp TR                    Allele contrast                   9          Random              1.037          0.885--1.215   0.659    0.0                   0.931    0.584

  Homozygous codominant       9                                 Random     0.756               0.434--1.317   0.323          0.0      0.729                 0.214    

  Heterozygous codominant     9                                 Random     1.117               0.930--1.341   0.236          0.0      0.644                 0.077    

  Dominant                    9                                 Random     1.083               0.907--1.293   0.377          0.0      0.834                 0.192    

  Recessive                   9                                 Random     0.724               0.417--1.259   0.253          0.0      0.681                 0.180    

  120 bp TR                   Allele contrast                   6          Random              1.189          1.040--1.358   0.011    37.1                  0.159    0.701

  Homozygous codominant       6                                 Random     1.291               0.892--1.868   0.176          47.2     0.092                 0.213    

  Heterozygous codominant     6                                 Random     1.010               0.744--1.372   0.949          22.9     0.262                 0.223    

  Dominant                    6                                 Random     1.152               0.837--1.584   0.386          34.3     0.179                 0.176    

  Recessive                   6                                 Random     1.275               1.081--1.504   0.004          33.1     0.187                 0.756    

  −521 T\>C                   Allele contrast                   10         Random              1.113          1.024--1.209   0.011    16.2                  0.294    0.628

  Homozygous codominant       10                                Random     1.240               1.041--1.477   0.016          18.7     0.271                 0.765    

  Heterozygous codominant     10                                Random     1.105               0.971--1.256   0.129          13.8     0.316                 0.751    

  Dominant                    10                                Random     1.136               1.004--1.289   0.043          19.2     0.266                 0.620    

  Recessive                   10                                Random     1.177               1.024--1.353   0.021          0.0      0.467                 0.812    

  −616 G\>C                   Allele contrast                   6          Random              1.103          0.991--1.226   0.071    6.7                   0.373    0.604

  Homozygous codominant       6                                 Random     0.637               0.469--0.866   0.004          46.4     0.096                 0.488    

  Heterozygous codominant     6                                 Random     1.123               0.974--1.296   0.110          0.0      0.986                 0.169    

  Dominant                    6                                 Random     1.133               0.991--1.295   0.068          0.0      0.889                 0.965    

  Recessive                   6                                 Random     1.140               0.840--1.548   0.400          48.3     0.085                 0.338    

  −376 C\>T                   Allele contrast                   4          Random              1.124          0.940--1.344   0.198    0.0                   0.707    0.200

  Homozygous codominant       4                                 Random     0.854               0.416--1.749   0.665          0.0      0.996                 0.456    

  Heterozygous codominant     4                                 Random     0.730               0.351--1.520   0.401          0.0      0.993                 0.911    

  Dominant                    4                                 Random     0.820               0.401--1.676   0.586          0.0      0.994                 0.583    

  Recessive                   4                                 Random     1.171               0.962--1.425   0.117          0.0      0.707                 0.214    
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------

**Notes:** L, long allele; S, short allele.

**Abbreviations:** CI, confidence interval; OR, odds ratio; 7R, 7 repeat; TR, tandem repeat; VNTR, variable number TR.

###### 

Subgroup associations of *DRD4* polymorphisms with schizophrenia

  Polymorphism                 Subgroup analysis   Studies (n)   OR             95% CI         *P*~z~   *P*~h~   *I*[@b2-ndt-14-153]
  ---------------------------- ------------------- ------------- -------------- -------------- -------- -------- ---------------------
  48 bp VNTR (7R and others)   Overall             22            1.095          0.953--1.259   0.349    0.352    8.1
  Ethnicity                                                                                                      
  Caucasian                    7                   1.127         0.924--1.375   0.238          0.195    30.6     
  East Asian                   11                  0.966         0.560--1.667   0.901          0.413    3.1      
  Indian                       1                   0.772         0.514--1.158   0.211          --       --       
  Mestizos                     1                   1.413         0.725--2.754   0.310          --       --       
  Israeli                      2                   1.164         0.739--1.835   0.512          0.441    0.0      
  Source of controls                                                                                             
  Population based             15                  1.031         0.796--1.336   0.816          0.242    18.9     
  Hospital based               7                   1.070         0.917--1.248   0.393          0.490    0.0      
  48 bp VNTR (S and L)         Overall             26            1.147          1.003--1.312   0.073    0.009    44.0
  Ethnicity                                                                                                      
  Caucasian                    8                   1.037         0.882--1.219   0.662          0.173    32.0     
  East Asian                   16                  1.165         0.919--1.475   0.206          0.014    49.1     
  Indian                       1                   1.179         0.815--1.705   0.382          --       --       
  Mestizos                     1                   1.949         1.007--3.770   0.048          --       --       
  Israeli                                                                                                        
  Source of controls                                                                                             
  Population based             18                  1.165         0.977--1.390   0.089          0.069    35.4     
  Hospital based               8                   1.091         0.862--1.381   0.468          0.016    59.2     
  12 bp TR                     Overall             10            1.083          0.907--1.293   0.377    0.834    0.0
  Ethnicity                                                                                                      
  Indian                       1                   0.927         0.533--1.612   0.788          --       --       
  Caucasian                    3                   0.787         0.509--1.218   0.283          0.611    0.0      
  East Asian                   4                   1.178         0.949--1.462   0.137          0.910    0.0      
  Israeli                      2                   1.312         0.642--2.679   0.456          0.610    0.0      
  Source of controls                                                                                             
  Population based             4                   1.133         0.908--1.413   0.270          0.710    0.0      
  Hospital based               6                   1.012         0.706--1.450   0.949          0.272    21.5     
  120 bp TR                    Overall             6             1.275          1.081--1.504   0.004    0.187    33.1
  Ethnicity                                                                                                      
  East Asian                   5                   1.317         1.108--1.565   0.002          0.196    33.9     
  Indian                       1                   0.979         0.629--1.524   0.924          --       --       
  Source of controls                                                                                             
  Population based             2                   1.102         0.892--1.360   0.368          0.551    0.0      
  Hospital based               4                   1.319         1.134--1.708   0.002          0.225    31.2     
  −521 T\>C                    Overall             10            1.177          1.024--1.353   0.021    0.467    0.0
  Ethnicity                                                                                                      
  Caucasian                    1                   1.136         0.670--1.925   0.636          --       --       
  East Asian                   8                   1.218         1.050--1.413   0.009          0.571    0.0      
  Indian                       1                   0.715         0.395--1.293   0.267                            
  Source of controls                                                                                             
  Population based             6                   1.188         0.972--1.451   0.092          0.258    23.5     
  Hospital based               4                   1.143         0.901--1.450   0.270          0.561    0.0      
  −616 G\>C                    Overall             6             1.133          0.991--1.295   0.068    0.889    0.0
  Source of controls                                                                                             
  Population based             2                   1.117         0.915--1.364   0.275          0.966    0.0      
  Hospital based               4                   1.146         0.956--1.317   0.140          0.645    0.0      
  −376 C\>T                    Overall             4             1.171          0.962--1.425   0.117    0.707    0.0
  Source of controls                                                                                             
  Population based             1                   1.079         0.805--1.447   0.611          --       --       
  Hospital based               3                   1.252         0.960--1.632   0.117          0.653    0.0      

**Notes:** L, long allele; S, short allele.

**Abbreviations:** CI, confidence interval; OR, odds ratio; 7R, 7 repeat; TR, tandem repeat; VNTR, variable number TR.

###### 

Genotype distribution and allele frequency of 12 bp TR

  Author                                                                         Genotype distribution   *P*~HWE~   Allele frequency                                                    
  ------------------------------------------------------------------------------ ----------------------- ---------- ------------------ ----- ----- ---- ------- ------- ------- ------- -------
  Petronis et al[@b48-ndt-14-153]                                                43                      6          1                  80    20    0    0.267   92.00   8.00    90.00   10.00
  Ohara et al[@b49-ndt-14-153]                                                   144                     9          0                  116   5     0    0.816   97.06   2.94    97.93   2.07
  Serretti et al[@b44-ndt-14-153],[@b69-ndt-14-153]                              184                     28         0                  225   37    1    0.689   0.93    0.07    0.93    0.07
  Aguirre et al[@b50-ndt-14-153]                                                 48                      34         1                  75    55    4    0.102   78.31   21.69   76.49   23.51
  Mitsuyasu et al[@b23-ndt-14-153],[a](#tfn15-ndt-14-153){ref-type="table-fn"}   136                     56         5                  176   53    10   0.027   83.20   16.70   84.70   15.30
  Kohn et al[@b43-ndt-14-153],[b](#tfn16-ndt-14-153){ref-type="table-fn"}        40                      9          0                  126   19    0    0.311   94.00   6.00    91.00   9.00
  Kohn et al[@b43-ndt-14-153],[c](#tfn17-ndt-14-153){ref-type="table-fn"}        44                      4          1                  53    6     0    0.416   94.00   6.00    94.00   6.00
  Hong et al[@b54-ndt-14-153]                                                    68                      10         2                  35    7     0    0.556   91.25   8.75    91.70   8.30
  Catalano et al[@b71-ndt-14-153]                                                76                      3          0                  69    6     0    0.718   98.10   1.90    96.00   4.00
  Nakajima et al[@b72-ndt-14-153]                                                413                     140        12                 431   119   18   0.008   85.50   14.50   86.50   13.50

**Notes:** *P*~HWE~, *P*-value of Hardy--Weinberg equilibrium.

Included 48 bp VNTR, 12 bp TR, and 120 bp TR.

Ethnicity is Ashkenazi which included Jews whose origin (or whose parents' origin), was in European countries, apart from the Balkans;

ethnicity is non-Ashkenazi which included Jews whose origin was in North Africa or Asia.

**Abbreviations:** de, deleted; in, inserted; TR, tandem repeat.

###### 

Genotype distribution and allele frequency of 120 bp TR

  Author                                                                         Genotype distribution   *P*~HWE~   Allele frequency                                                    
  ------------------------------------------------------------------------------ ----------------------- ---------- ------------------ ---- ----- ----- ------- ------- ------- ------- -------
  Mitsuyasu et al[@b23-ndt-14-153],[a](#tfn20-ndt-14-153){ref-type="table-fn"}   10                      75         129                13   87    139   0.898   77.80   22.20   76.40   23.60
  Pai et al[@b73-ndt-14-153]                                                     23                      77         87                 11   61    64    0.501   32.90   67.10   30.50   69.50
  Xing et al[@b18-ndt-14-153]                                                    20                      77         113                28   98    80    0.816   27.90   72.10   37.40   62.60
  Nakajima et al[@b72-ndt-14-153]                                                24                      183        362                33   192   345   0.363   20.00   80.00   23.00   78.00
  Tsutsumi et al[@b19-ndt-14-153]                                                24                      138        248                16   158   211   0.041   22.68   77.32   24.68   75.32
  Lai et al[@b74-ndt-14-153]                                                     28                      161        133                40   166   94    0.013   33.70   66.30   41.00   59.00

**Notes:** L, long allele; *P*~HWE~, *P*-value of Hardy--Weinberg equilibrium; S, short allele.

Included 48 bp VNTR, 12 bp TR, and 120 bp TR.

**Abbreviation:** TR, tandem repeat.

###### 

Genotype distribution and allele frequency of −521 C\>T

  Author                                                                         Genotype distribution   *P*~HWE~   Allele frequency                                                    
  ------------------------------------------------------------------------------ ----------------------- ---------- ------------------ ---- ----- ----- ------- ------- ------- ------- -------
  Okuyama et al[@b22-ndt-14-153]                                                 58                      125        69                 38   142   89    0.119   48.00   52.00   41.00   59.00
  Mitsuyasu et al[@b23-ndt-14-153],[a](#tfn23-ndt-14-153){ref-type="table-fn"}   33                      106        67                 31   115   93    0.623   41.75   58.25   37.05   62.95
  Mitsuyasu et al[@b75-ndt-14-153],[b](#tfn24-ndt-14-153){ref-type="table-fn"}   25                      122        61                 25   110   75    0.109   41.30   58.70   38.10   61.90
  Lung et al[@b58-ndt-14-153]                                                    80                      320        230                48   204   173   0.294   38.10   61.90   35.30   64.70
  Jonsson et al[@b24-ndt-14-153]                                                 23                      74         35                 60   205   118   0.061   45.50   54.50   42.00   58.00
  Pai et al[@b73-ndt-14-153]                                                     27                      92         62                 26   77    29    0.055   40.30   59.70   48.90   51.10
  Xing et al[@b18-ndt-14-153]                                                    37                      103        70                 25   111   70    0.059   42.10   57.90   39.10   60.90
  Nakajima et al[@b72-ndt-14-153]                                                106                     270        190                89   285   195   0.368   43.00   58.00   41.00   59.00
  Lai et al[@b74-ndt-14-153]                                                     87                      115        120                81   95    124   --      44.88   55.12   42.83   57.17
  Zhong et al[@b76-ndt-14-153]                                                   62                      78         60                 53   64    83    --      45.91   54.09   42.50   57.50

**Notes:** *P*~HWE~, *P*-value of Hardy--Weinberg equilibrium.

Included 48 bp VNTR, 12 bp TR, and 120 bp TR;

did not include 48 bp VNTR, 12 bp TR, and 120 bp TR.

**Abbreviation:** TR, tandem repeat.

###### 

Genotype distribution and allele frequency of −616 C\>G

  Author                                                                         Genotype distribution   *P*~HWE~   Allele frequency                                                    
  ------------------------------------------------------------------------------ ----------------------- ---------- ------------------ ----- ----- ---- ------- ------- ------- ------- -------
  Mitsuyasu et al[@b23-ndt-14-153],[a](#tfn27-ndt-14-153){ref-type="table-fn"}   102                     89         19                 112   98    30   0.243   69.80   30.20   67.10   32.90
  Mitsuyasu et al[@b75-ndt-14-153],[b](#tfn28-ndt-14-153){ref-type="table-fn"}   89                      89         30                 100   85    25   0.296   64.20   35.80   67.90   32.10
  Xing et al[@b18-ndt-14-153]                                                    83                      100        27                 91    102   13   0.025   63.30   36.70   68.90   31.10
  Nakajima et al[@b72-ndt-14-153]                                                267                     248        49                 285   224   59   0.134   69.00   31.00   69.50   29.50
  Lai et al[@b74-ndt-14-153]                                                     161                     113        48                 166   102   32   0.009   67.55   32.45   72.33   27.67
  Zhong et al[@b76-ndt-14-153]                                                   112                     77         31                 107   68    25   0.010   68.41   31.59   70.50   29.50

**Notes:** *P*~HWE~, *P*-value of Hardy--Weinberg equilibrium.

Included 48 bp VNTR, 12 bp TR, and 120 bp TR;

did not include 48 bp VNTR, 12 bp TR, and 120 bp TR.

**Abbreviation:** TR, tandem repeat.

###### 

Genotype distribution and allele frequency of −376 C\>T

  Author                                                                         Genotype distribution   *P*~HWE~   Allele frequency                                                   
  ------------------------------------------------------------------------------ ----------------------- ---------- ------------------ ----- ----- --- ------- ------- ------- ------- -------
  Mitsuyasu et al[@b23-ndt-14-153],[a](#tfn31-ndt-14-153){ref-type="table-fn"}   177                     34         1                  193   43    1   0.39    91.50   8.50    90.45   9.45
  Mitsuyasu et al[@b75-ndt-14-153],[b](#tfn32-ndt-14-153){ref-type="table-fn"}   179                     28         1                  168   41    1   0.367   92.80   0.72    89.80   1.02
  Xing et al[@b74-ndt-14-153]                                                    137                     66         7                  127   74    5   0.126   81.00   19.00   79.60   20.40
  Nakajima et al[@b72-ndt-14-153]                                                453                     100        8                  447   108   7   0.869   90.00   10.00   89.50   10.50

**Notes:** *P*~HWE~, *P*-value of Hardy--Weinberg equilibrium.

Included 48 bp VNTR, 12 bp TR, and 120 bp TR;

did not include 48 bp VNTR, 12 bp TR, and 120 bp TR.

**Abbreviation:** TR, tandem repeat.
